Perrigo Company plc (NYSE:PRGO - Get Free Report) EVP Ronald Craig Janish sold 7,800 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the transaction, the executive vice president now directly owns 33,666 shares of the company's stock, valued at $923,795.04. This represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Perrigo Price Performance
Shares of PRGO stock traded up $0.42 during mid-day trading on Friday, hitting $27.26. 1,264,717 shares of the stock were exchanged, compared to its average volume of 1,438,513. Perrigo Company plc has a 52-week low of $23.14 and a 52-week high of $33.46. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The company has a market cap of $3.72 billion, a PE ratio of -23.30 and a beta of 0.48. The firm has a fifty day moving average of $25.42 and a 200 day moving average of $26.21.
Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 EPS for the quarter, beating analysts' consensus estimates of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.20 billion. Research analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current year.
Perrigo Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th will be paid a $0.29 dividend. The ex-dividend date is Friday, March 7th. This is a positive change from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.26%. Perrigo's payout ratio is currently -92.80%.
Analyst Ratings Changes
PRGO has been the subject of several recent research reports. StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Argus cut Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Finally, Piper Sandler lowered Perrigo from an "overweight" rating to a "neutral" rating and dropped their target price for the stock from $34.00 to $27.00 in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $33.00.
View Our Latest Stock Analysis on PRGO
Institutional Trading of Perrigo
Several large investors have recently made changes to their positions in the company. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Perrigo during the 4th quarter worth $383,000. University of Texas Texas AM Investment Management Co. boosted its position in Perrigo by 12.0% during the fourth quarter. University of Texas Texas AM Investment Management Co. now owns 38,424 shares of the company's stock worth $988,000 after acquiring an additional 4,105 shares during the last quarter. Novem Group purchased a new stake in Perrigo during the 4th quarter valued at about $2,601,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Perrigo by 14.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 480,961 shares of the company's stock valued at $12,366,000 after acquiring an additional 61,824 shares during the last quarter. Finally, iSAM Funds UK Ltd purchased a new position in Perrigo in the 4th quarter worth approximately $242,000. 95.91% of the stock is currently owned by hedge funds and other institutional investors.
About Perrigo
(
Get Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also
Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
